Javier Espinosa

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 578 citations

5-Year Analysis, Breast Oncology, Oncology +10

SARCOPTIC MANGE IN SPANISH IBEX FROM SPAIN

Luís León-Vizcaíno, R. Ruíz de Ybáñez, María José Cubero Pablo et al. · Journal of Wildlife Diseases · 1999 · 157 citations · Full text

Parasitic Disease, Spanish Ibex, Zoonotic Disease +9

Prediction of Serious Complications in Patients With Seemingly Stable Febrile Neutropenia: Validation of the Clinical Index of Stable Febrile Neutropenia in a Prospective Cohort of Patients From the FINITE Study

Alberto Carmona‐Bayonas, Paula Jiménez‐Fonseca, Juan Virizuela Echaburu et al. · Journal of Clinical Oncology · 2015 · 156 citations · Full text

Serum albumin and other prognostic factors related to response and survival in patients with advanced non-small cell lung cancer

Enrique Espinosa, Jaime Feliú, P. Zamora et al. · Lung Cancer · 1995 · 118 citations

Prognostic Biomarkers, Serum Albumin, Medicine +8

Hartmann’s operation: how often is it reversed and at what cost? A multicentre study

José V. Roig, Míriam Cantos, Zutoia Balciscueta et al. · Colorectal Disease · 2011 · 94 citations